Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Captopril in Diabetic Nephropathy
NCT00663949Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pentoxifylline in diabetic nephropathy (DN), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Urinary protein at 6 months. Started Feb 2006; status: completed.
02
Drugs
pentoxifylline
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00663949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663949.